FFO
EDIT icon

Fortitude Family Office’s Editas Medicine EDIT Stock Holding History

Fortitude Family Office’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94K Hold
600
– – ﹤0.01% 1490
2026
Q1 		$1.48K Buy
600
+275
+85% +$582 ﹤0.01% 1385
2025
Q4 		$666 Hold
325
– – ﹤0.01% 1609
2025
Q3 		$1.13K Hold
325
– – ﹤0.01% 1500
2025
Q2 		$715 Buy
+325
New +$532 ﹤0.01% 1654

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fortitude Family Office's EDIT Position: Q2 2026 in Review

Fortitude Family Office held its Editas Medicine (EDIT) position steady in Q2 2026 at 600 shares worth $1.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

Fortitude Family Office first reported a position in EDIT in Q2 2025 and has held it in 5 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Fortitude Family Office held 600 shares of Editas Medicine worth $1.94K as of Q2 2026.
  • Fortitude Family Office left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1490 holding.
  • Fortitude Family Office first reported a position in Editas Medicine in Q2 2025 and has held it in 5 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.